awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37575815-A6F84E61-1F64-4F20-8A4D-4FC26C685C5B
Q37575815-A6F84E61-1F64-4F20-8A4D-4FC26C685C5B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37575815-A6F84E61-1F64-4F20-8A4D-4FC26C685C5B
Signalling pathways in prostate carcinogenesis: potentials for molecular-targeted therapy.
P2860
Q37575815-A6F84E61-1F64-4F20-8A4D-4FC26C685C5B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37575815-A6F84E61-1F64-4F20-8A4D-4FC26C685C5B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a477490d787bf3f85f97140d5c5eebd22408766a
P2860
A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer.